Celltrion Pharm, Inc. (KOSDAQ:068760)
61,300
+1,100 (1.83%)
At close: Mar 20, 2026
15.15% (1Y)
| Market Cap | 2.67T +17.0% |
| Revenue (ttm) | 274.73B +53.2% |
| Net Income | 26.03B +146.8% |
| EPS | 583.36 +146.0% |
| Shares Out | 43.50M |
| PE Ratio | 105.08 |
| Forward PE | n/a |
| Dividend | 200.00 (0.33%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 69,614 |
| Average Volume | 137,564 |
| Open | 60,400 |
| Previous Close | 60,200 |
| Day's Range | 60,300 - 61,300 |
| 52-Week Range | 43,627 - 78,300 |
| Beta | 1.10 |
| RSI | 41.32 |
| Earnings Date | n/a |